Medical Device Cleaning Market Overview
As per Econ Market Research analysis, the Global Medical Device Cleaning Market accounted for US$ 27.72 Billion in 2026 and is expected to surpass US$ 65.91 Billion by 2035, witnessing a CAGR of 10.1% throughout 2026–2035. The analysis is based on 2025 as the base year.
The Medical Device Cleaning Market covers the products, systems, chemistries, and validated workflows used to remove blood, tissue, proteins, biofilm, and other contamination from reusable clinical equipment. Reprocessing normally progresses through sequential point-of-use treatment, thorough cleaning in a designated decontamination area, and final disinfection or sterilization according to the device’s intended clinical use. Cleaning quality directly affects the effectiveness of later microbial-control steps because residual organic matter can interfere with disinfectants and sterilants. Hospitals therefore treat cleaning as a controlled patient-safety process rather than a basic housekeeping function. Device geometry has become a major purchasing factor, particularly for endoscopes, cannulated surgical instruments, robotic instruments, respiratory equipment, and heat-sensitive devices with internal channels. Validation protocols increasingly examine realistic clinical soils, material compatibility, water quality, detergent concentration, contact conditions, mechanical action, and rinsing performance before a reusable device is released for another patient procedure.
The U.S. Medical Device Cleaning Market is supported by extensive hospital sterile-processing infrastructure, ambulatory surgery activity, endoscopy services, dental care, and strict federal expectations for reusable-device reprocessing. Infection prevention remains a central operational requirement because the latest national prevalence survey found that 1 in 38 hospitalized patients had at least one healthcare-associated infection on a given day in the surveyed population. U.S. healthcare facilities use manufacturer instructions for use, validated cleaning methods, high-level disinfection, low-temperature processing, steam sterilization, and automated washer-disinfectors according to device risk classification. Regulatory review also places emphasis on reprocessing instructions for devices that present higher microbial-transmission risk when inadequately cleaned. This environment supports demand for enzymatic detergents, automated endoscope reprocessors, ultrasonic systems, cleaning verification products, instrument lubricants, washer-disinfectors, disinfectants, and traceability software. Purchasing decisions increasingly consider reproducibility, audit documentation, staff ergonomics, device compatibility, and reduced variation between operators.
European demand for medical device cleaning products is shaped by mature hospital networks, national infection-control programs, centralized sterile-services departments, endoscopy reprocessing requirements, and formal quality-management procedures. Surveillance data demonstrate the scale of infection-prevention activity, with 4.3 million patients in EU/EEA hospitals acquiring at least one healthcare-associated infection each year. Hospitals across Germany, France, the U.K., Italy, Spain, the Nordic countries, and other European markets are adopting automated cleaning equipment alongside validated chemical formulations for surgical instruments and heat-sensitive devices. Sustainability is also becoming a procurement consideration because washer-disinfectors consume water, energy, detergent, and thermal resources during repeated processing cycles. Manufacturers are responding with lower-consumption equipment, optimized detergent dosing, digital monitoring, and systems designed for central sterile departments with high instrument throughput. European facilities also place strong attention on staff training, workflow separation between contaminated and clean zones, process verification, and compliance documentation.
Medical Device Cleaning Market Latest Trends
The Medical Device Cleaning Market is shifting toward automated, standardized, and traceable reprocessing. Hospitals are replacing highly operator-dependent workflows with washer-disinfectors, automated endoscope processors, centralized detergent-dosing systems, ultrasonic cleaning platforms, and digital process-monitoring tools. Automation is particularly important for complex devices because narrow lumens, hinges, channels, and textured surfaces can retain biological soil when manual cleaning is inconsistent. Manufacturers are therefore integrating controlled dosing, programmed cycles, wash-monitoring products, residual-protein testing, and digital records into sterile-processing workflows.
Another trend is greater emphasis on sustainability without reducing microbial-control performance. Newer washer-disinfectors are designed to adjust water and chemistry use to the actual load, lowering unnecessary utility consumption while preserving validated cleaning conditions. Hospitals are also evaluating detergent concentration, rinse requirements, equipment footprint, energy demand, and instrument compatibility as part of lifecycle procurement. This trend favors concentrated chemistries, intelligent dosing, water-efficient equipment, and systems that reduce reprocessing variability.
Complex endoscope reprocessing remains a major innovation area. Providers increasingly use automated systems for heat-sensitive devices because these systems control fluid circulation, chemical exposure, rinsing, and workflow sequence more consistently than open manual soaking. Instrument-cleaning chemistries are also moving toward low-foaming, material-compatible formulations that remove protein and biological residues without accelerating corrosion or damaging polymers, optics, seals, or instrument coatings. Digital verification, faster biological monitoring, automated record generation, and integrated sterile-processing analytics are becoming additional differentiators for suppliers competing in the Medical Device Cleaning Market.
Medical Device Cleaning Market Dynamics
Medical Device Cleaning Market dynamics are governed by infection-control requirements, surgical instrument utilization, device complexity, sterile-processing capacity, labor availability, regulatory expectations, and healthcare infrastructure investment. U.S. healthcare systems continue to face a substantial infection-prevention burden, with national estimates identifying over 680000 healthcare-associated infections in hospitals during a year. Reusable-device reprocessing therefore remains an essential safety function rather than an optional operational activity. Demand is strongest where facilities process large volumes of endoscopes, surgical instruments, anesthesia equipment, dental tools, and other reusable devices. Suppliers compete through chemistry performance, automation, device compatibility, documentation, sustainability, and service support.
Drivers of Market Growth
Increasing focus on preventing infections associated with reusable medical devices.
Healthcare-associated infections create strong institutional demand for validated cleaning, disinfection, and sterilization workflows. Infection surveillance programs have expanded the visibility of cleaning quality, while accreditation requirements encourage hospitals to document device handling from point of use through storage. A European surveillance program collected data from 1623 hospitals, demonstrating the scale at which healthcare organizations are measuring infection-prevention performance. Reusable instruments can transfer biological material when cleaning is incomplete, making removal of blood, tissue, protein, and microbial contamination essential before high-level disinfection or sterilization.
This driver is particularly important for flexible endoscopes, bronchoscopes, surgical instruments, anesthesia devices, and equipment containing channels or difficult-to-access joints. Healthcare providers increasingly prefer cleaning systems with repeatable cycles, automated dosing, verification tools, and documented process parameters. Manufacturers that can demonstrate reliable performance against clinically relevant soils gain an advantage because regulators expect cleaning instructions to be scientifically validated. The Medical Device Cleaning Market consequently benefits from the direct connection between reprocessing consistency, infection prevention, patient safety, and hospital quality management.
Market Restraints
Increasing adoption of disposable and single-use medical devices.
Single-use products can reduce the number of reusable instruments entering hospital reprocessing departments. Some providers select disposable alternatives for procedures involving difficult-to-clean components because these products remove the need for repeated cleaning, disinfection, packaging, sterilization, and reprocessing documentation. The restraint is strongest when the labor, turnaround time, validation burden, repair cost, and contamination risk of a reusable device become operationally difficult to justify.
The effect varies by clinical specialty. High-value surgical instrument sets remain strongly dependent on reprocessing, while certain endoscopic accessories, tubing products, probes, and procedure-specific devices are increasingly available in disposable formats. Regulators also require reprocessors of eligible single-use devices to meet applicable validation requirements before such devices can legally re-enter clinical use. This limits uncontrolled reuse but also reinforces the competitive position of products designed to be discarded after the intended procedure. For cleaning-system manufacturers, the challenge is to demonstrate that reusable workflows provide dependable safety, instrument longevity, operational efficiency, and environmental advantages that offset the convenience of disposable alternatives.
Market Opportunities
Expanding adoption of automated sterile-processing and endoscope-reprocessing systems.
Automation provides a major opportunity in the Medical Device Cleaning Market because hospitals are seeking repeatable results while reducing operator variation. Automated washer-disinfectors can control temperature, detergent delivery, spray pressure, rinse stages, and thermal-disinfection parameters within validated cycles. Automated endoscope processors similarly improve control over fluid circulation and chemical contact inside complex channels. These systems support standardization across multi-site hospital networks and can simplify documentation during quality audits.
Digital connectivity increases the opportunity further. Sterile-processing departments can integrate cleaning equipment with cycle records, instrument tracking, chemical-management platforms, maintenance schedules, and workflow analytics. Suppliers can therefore generate recurring demand through detergents, indicators, accessories, equipment servicing, software, preventive maintenance, and replacement components rather than relying only on capital-equipment sales. Emerging hospital systems in Asia-Pacific, the Middle East, and other developing healthcare markets also create opportunities to build centralized sterile-processing infrastructure from the outset rather than upgrading fragmented manual departments. Suppliers offering scalable equipment, training, validation support, and local service networks can capture demand as facilities formalize infection-control procedures.
Market Challenges
Growing complexity of reusable medical devices and cleaning-validation requirements.
Modern reusable devices increasingly incorporate long lumens, articulating joints, optical components, polymers, electronics, delicate coatings, and components that cannot tolerate every disinfectant or sterilization method. These design characteristics make effective cleaning difficult because contamination can remain in internal surfaces that are inaccessible to direct visual inspection. Manufacturers must therefore develop cleaning instructions that can be executed reliably by healthcare staff using available equipment and chemistry.
Regulators emphasize clear reprocessing labeling and scientifically supported validation. Federal guidance identifies six criteria that reusable-device instructions should address so users can understand and correctly perform the required procedure. Cleaning validation must also simulate realistic contamination and worst-case clinical conditions rather than rely on irrelevant surrogate testing. These expectations increase product-development complexity for device manufacturers and create additional training requirements for hospitals. The Medical Device Cleaning Market must consequently balance stronger cleaning performance with material compatibility, safe chemical exposure, staff usability, cycle efficiency, and regulatory evidence.
Medical Device Cleaning SWOT Analysis
Strengths
Medical device cleaning is an essential clinical workflow because reusable instruments cannot proceed safely to disinfection or sterilization when residual organic soil remains.
Demand spans hospitals, ambulatory surgical centers, dental facilities, endoscopy units, diagnostic settings, and centralized reprocessing operations.
Suppliers can combine equipment, detergents, disinfectants, indicators, accessories, maintenance, software, and validation services into integrated offerings.
Regulatory scrutiny creates durable demand for scientifically validated processes, standardized instructions, traceability, and quality-control documentation.
Weaknesses
Medical device cleaning remains labor-intensive when facilities rely heavily on manual sink cleaning and visual inspection.
Incorrect detergent concentration, inadequate brushing, poor water quality, delayed point-of-use treatment, or incomplete device disassembly can reduce process effectiveness.
Capital-intensive washer-disinfectors and automated endoscope processors can be difficult for smaller healthcare facilities to procure and maintain.
Device-specific instructions create operational complexity because a single sterile-processing department may handle instruments with very different material and cleaning requirements.
Opportunities
Automated washer-disinfectors can replace inconsistent manual processes in high-throughput sterile-processing departments.
Digitized cycle records can improve traceability, audit readiness, preventive maintenance, and quality assurance.
Enzymatic and material-compatible chemistries can address difficult biological soils while protecting expensive reusable instruments.
Healthcare infrastructure expansion in developing economies creates demand for modern sterile-processing departments, training programs, and outsourced reprocessing services.
Threats
Disposable medical devices can reduce the number of reusable products requiring repeated cleaning.
Regulatory actions can disrupt product portfolios when equipment, chemistry, labeling, or validated processes fail to meet required standards.
Aggressive competition can pressure consumable pricing where hospitals standardize procurement across large networks.
Chemical-resistance concerns, occupational exposure issues, environmental restrictions, and sustainability requirements can reduce acceptance of legacy formulations.
Medical Device Cleaning Segmentation Analysis
The Medical Device Cleaning Market can be evaluated by device risk, cleaning technique, and EPA classification. These segmentation structures reflect the level of microbial control required after an instrument contacts intact skin, mucous membranes, non-intact tissue, sterile tissue, or the vascular system. Device classification influences whether cleaning is followed by low-level disinfection, high-level disinfection, or sterilization. Technique segmentation identifies the physical and chemical processes used to remove contamination and control microorganisms. EPA classification further differentiates disinfectants according to their intended microbial-control performance. Together, these categories help hospitals select suitable chemistries, equipment, process controls, and reprocessing methods for specific clinical instruments.
By Device
Semi-critical devices represent the leading device category and accounted for 45.98% of the global market in the referenced base-year analysis. Semi-critical products include devices that contact mucous membranes or non-intact skin and therefore require rigorous cleaning followed by high-level disinfection or another validated reprocessing method. Endoscopes, respiratory therapy equipment, laryngoscope components, and selected dental instruments are important examples.
Critical devices enter sterile tissue or the vascular system and require the highest level of reprocessing assurance. Surgical instruments, implants intended for reuse during processing, and selected invasive devices must be thoroughly cleaned before sterilization because residual organic matter can compromise later processing stages. Non-critical devices contact intact skin and generally require less aggressive microbial-control procedures, but cleaning remains necessary to remove visible contamination. The Medical Device Cleaning Market therefore serves distinct risk levels while maintaining cleaning as the foundational step across all device classes.
By Technique
Cleaning, disinfection, and sterilization represent separate but connected technique groups. Disinfection held a 52.2% share in an established global segmentation benchmark, reflecting the extensive use of high-level and intermediate disinfectants for reusable equipment that does not always require terminal sterilization. Cleaning includes detergents, buffers, chelators, enzymes, and other formulations designed to detach organic and inorganic soils before microbial-control treatment.
Detergents remove blood, fats, and particulate contamination, while enzymatic formulations target proteins and other biological residues. Chelators can assist with mineral-related contamination, and buffers stabilize formulation conditions. Disinfection includes chemical systems, metal-based approaches, ultraviolet methods, and other technologies selected according to device compatibility and clinical risk. Sterilization includes heat sterilization, ethylene oxide processing, and radiation methods. Heat is widely used for compatible instruments, while alternative techniques support devices that cannot tolerate high processing temperatures.
By EPA Classification
EPA classification divides disinfectants into high-level, intermediate-level, and low-level categories according to intended antimicrobial performance and clinical use. High-level products represented 45.3% of a recent global market classification, reflecting their importance in reprocessing heat-sensitive semi-critical devices such as endoscopes and selected respiratory or dental instruments.
Intermediate-level disinfectants are used where broader microbial activity is required than low-level surface treatment but full high-level disinfection is not indicated. They are relevant to clinical equipment and surfaces exposed to blood or body fluids according to approved labeling. Low-level disinfectants serve non-critical equipment that contacts intact skin and environmental surfaces associated with routine patient care. Hospitals select the classification according to device risk, pathogen-control requirements, manufacturer instructions, contact conditions, and regulatory labeling rather than applying one disinfectant type across every reusable device.
Regional Analysis
Regional Medical Device Cleaning Market performance reflects differences in hospital infrastructure, surgical activity, reusable-device utilization, infection-control enforcement, sterile-processing maturity, labor cost, and equipment automation. North America and Europe contain mature central sterile-services networks, while Asia-Pacific is expanding rapidly through hospital construction, medical tourism, healthcare modernization, and higher adoption of automated processing. Middle Eastern markets are investing in advanced tertiary hospitals and centralized processing departments, while African demand varies widely between major urban healthcare centers and resource-constrained facilities.
North America: North America held 37% of the global Medical Device Cleaning Market in the referenced regional assessment. The region benefits from established sterile-processing departments, widespread automated washer-disinfector adoption, sophisticated endoscopy services, and formal regulatory oversight for reusable medical devices. Hospitals maintain detailed instructions for instrument decontamination, cleaning, disinfection, sterilization, storage, and transport.
U.S. facilities represent the largest component of regional demand, supported by major academic medical centers, surgical hospitals, outpatient centers, specialty clinics, and dental networks. Infection-prevention programs encourage facilities to standardize chemistry, equipment, monitoring, and documentation across hospital systems. Automated reprocessing is also attractive where labor shortages make manual workflows difficult to scale.
Canada contributes through mature public healthcare infrastructure and infection-control requirements across provincial systems. Regional manufacturers and multinational suppliers compete through local service teams, equipment maintenance, chemistry contracts, training, and sterile-processing consulting. North American purchasing decisions increasingly consider total workflow efficiency, instrument protection, traceability, utility use, turnaround time, and compatibility with complex reusable devices.
Europe: Europe accounts for 28% of the Medical Device Cleaning Market in the cited geographic assessment. Demand is supported by established hospital systems in Germany, the U.K., France, Italy, Spain, the Nordic region, Switzerland, Benelux, and other markets with formal infection-prevention requirements. European hospitals frequently use centralized sterile supply departments to separate contaminated receiving areas from cleaning, inspection, packaging, sterilization, and clean-storage zones.
Sustainability has become an important equipment-development theme. Hospitals are evaluating water use, energy consumption, detergent utilization, equipment loading efficiency, and waste associated with repeated instrument processing. European manufacturers are responding with automated dosing, resource-efficient washers, multi-chamber systems, process monitoring, and digital control platforms.
The region also contains major equipment and infection-prevention suppliers, supporting competition in washer-disinfectors, sterilizers, cleaning chemistry, endoscope reprocessing, automation, and service contracts. Infection surveillance remains a strong policy driver, while aging populations and complex surgical procedures sustain reusable-instrument throughput. Procurement increasingly favors systems capable of integrating infection prevention with operational efficiency and environmental performance.
Asia-Pacific: Asia-Pacific holds 22% of the Medical Device Cleaning Market in the referenced regional analysis. China, Japan, India, South Korea, Australia, and Southeast Asian healthcare systems represent distinct demand profiles, ranging from highly automated tertiary hospitals to facilities transitioning from manual processing toward formal sterile-processing departments.
China supports demand through large hospital networks and continued healthcare modernization. Japan and South Korea maintain high standards for medical technology and reusable-device handling, creating demand for precision cleaning, automation, and device-compatible chemistries. India presents significant opportunity through private hospital expansion, medical tourism, surgical growth, and investment in infection-control infrastructure.
Manufacturers entering Asia-Pacific increasingly combine equipment sales with installation, validation, training, preventive maintenance, and local technical support. Outsourced sterilization and specialized reprocessing services are also gaining relevance where healthcare providers seek access to validated technology without building every capability internally. Local manufacturing and regional supply chains can further improve equipment availability and consumable delivery.
Middle East & Africa: The Middle East & Africa represents a 6% share in a recent regional market assessment. Demand is concentrated in GCC healthcare systems, South Africa, and major metropolitan hospital clusters where providers are investing in tertiary care, surgery, endoscopy, oncology, transplantation, and other instrument-intensive specialties.
Gulf countries are building modern hospitals that frequently incorporate centralized sterile-processing departments into facility design. This supports adoption of automated washer-disinfectors, cart washers, sterilization systems, water-treatment equipment, instrument tracking, and specialized detergents. Hospitals also seek international accreditation, strengthening interest in documented infection-control processes and staff competency.
African markets are more heterogeneous. Large private hospitals and national referral centers can support advanced automated systems, while smaller facilities may depend heavily on manual cleaning because of infrastructure, water-quality, maintenance, or capital constraints. Suppliers that offer scalable equipment, robust service networks, staff training, and dependable consumable distribution have stronger prospects in this region.
Competitive Landscape
The Medical Device Cleaning Market includes multinational infection-prevention companies, sterile-processing equipment manufacturers, chemical specialists, contract sterilization providers, and niche instrument-care suppliers. Competition centers on cleaning efficacy, compatibility with reusable devices, automation, washer throughput, chemical dosing, endoscope reprocessing, validation evidence, digital traceability, utility efficiency, and technical service. A cleaning-focused competitive benchmark places the combined share of the leading five suppliers at 33%, indicating that established companies hold meaningful positions while a substantial portion of demand remains distributed among regional and specialized vendors.
STERIS competes across cleaning chemistry, endoscope reprocessing, sterile-processing equipment, sterilization, monitoring, maintenance, and outsourced services. Getinge has a strong position in washer-disinfectors, central sterile department infrastructure, detergent systems, automation, and workflow equipment. Ecolab participates through instrument-cleaning chemistry and infection-prevention programs, while Advanced Sterilization Products emphasizes low-temperature sterilization and sterility assurance.
Belimed and Steelco compete strongly in automated washing and sterile-processing infrastructure. Ruhof, Metrex Research, Oro Clean Chemie, Sklar, and other specialist suppliers compete through concentrated chemistries, instrument care, dental and surgical applications, specialty disinfectants, and focused distribution. Competitive advantage increasingly depends on providing an integrated reprocessing solution rather than a standalone chemical product.
List of Top Medical Device Cleaning Companies
STERIS plc (Ireland)
Getinge AB (Sweden)
Ecolab Inc. (U.S.)
Advanced Sterilization Products (U.S.)
Ruhof Corporation (U.S.)
Metrex Research, LLC (U.S.)
Sklar Surgical Instruments (U.S.)
Belimed AG (Switzerland)
Steelco S.p.A. (Italy)
Sterigenics U.S., LLC (U.S.)
Oro Clean Chemie AG (Switzerland)
Leading Companies by Market Share
STERIS plc: An established industry benchmark estimated STERIS at a 30–32% market share, supported by its broad portfolio spanning cleaning products, sterilization equipment, infection prevention, service operations, and global distribution.
Getinge AB: Published competitive estimates place Getinge within a 20–30% market-share band in defined medical device cleaning assessments, supported by its washer-disinfector portfolio, detergents, sterile-processing automation, and global hospital relationships.
Investment Trends & Opportunities
Investment in the Medical Device Cleaning Market is moving toward automation, centralized sterile processing, endoscope reprocessing, digital quality assurance, and resource-efficient equipment. Healthcare providers are directing capital toward washer-disinfectors, ultrasonic systems, automated loading, chemical-management systems, instrument tracking, and sterile-processing department redesign. Investors and manufacturers also see opportunities in recurring consumables because detergents, indicators, disinfectants, filters, accessories, testing products, and service contracts create continuing demand after equipment installation.
Asia-Pacific is an important investment destination because hospital expansion is creating opportunities to install modern reprocessing systems rather than extend legacy manual workflows. Contract sterilization and outsourced reprocessing provide another opportunity, particularly for device manufacturers and healthcare providers seeking validated specialist capacity. STERIS expanded Asian processing infrastructure through a new Malaysian ethylene oxide facility in 2025, illustrating continued investment in regional medical-device processing capacity.
Sustainability is also influencing capital allocation. Hospitals are increasingly interested in equipment that reduces water, chemistry, and energy consumption while preserving validated performance. Suppliers can differentiate by combining process engineering with measurable utility efficiency. Additional investment opportunities exist in training, validation consulting, digital traceability, equipment maintenance, cleaning-verification technologies, and regional service networks.
Product Innovation & Development
Product innovation in the Medical Device Cleaning Market is increasingly focused on automation, process verification, resource efficiency, and cleaning of complex heat-sensitive devices. Modern washer-disinfectors use programmable cycles, controlled detergent dosing, improved spray coverage, digital interfaces, and workflow automation to reduce manual variation. Newer systems can alter water and detergent use according to the processing load, helping sterile-processing departments improve efficiency without removing required cleaning stages.
Endoscope reprocessing is another major development area. STERIS offers a cleaning and liquid chemical sterilant processing platform with a validated 38-minute cycle for reusable heat-sensitive medical devices. Systems of this type integrate cleaning with controlled downstream processing, reducing reliance on open manual workflows and improving repeatability for complex scopes.
Chemical development is progressing toward low-foaming, residue-conscious, material-compatible products for manual and automated instrument processing. Enzymatic formulations are designed to break down difficult biological contamination, while descalers and lubricants support instrument condition throughout repeated reprocessing. Monitoring innovation is advancing simultaneously through residual-protein tests, wash indicators, rapid biological indicators, digital cycle documentation, and equipment connectivity. Product differentiation increasingly depends on the ability to combine cleaning performance, staff usability, instrument protection, sustainability, and auditable quality assurance.
Recent Developments (2023–2026)
In April 2026, Intercon Chemical introduced Cleaner LS and Cleaner MD as dedicated cleaning brands designed to expand its participation in medical-device and healthcare cleaning applications.
In November 2025, Getinge launched the Aquadis 44 washer-disinfector with adaptive water filling and automated detergent adjustment intended to improve resource efficiency during instrument reprocessing.
In August 2025, Advanced Sterilization Products launched the BIOTRACE Instant Read system to accelerate biological monitoring and support faster decision-making within sterile-processing departments.
In May 2025, Sterigenics announced expansion of its North Carolina operations with a new X-ray sterilization facility intended to increase advanced processing capacity for medical-device customers.
In July 2024, Advanced Sterilization Products received U.S. clearance for the ULTRA GI cycle used with its STERRAD platform for compatible duodenoscope sterilization.
Scope of the Medical Device Cleaning Market Report
The Medical Device Cleaning Market report covers the global ecosystem for cleaning, disinfecting, and reprocessing reusable medical equipment through 2035. The scope includes hospitals, sterile-processing departments, outpatient facilities, endoscopy centers, dental settings, specialized clinics, and other healthcare environments that repeatedly process reusable instruments.
The report analyzes devices as non-critical, semi-critical, and critical according to clinical contact and reprocessing requirements. Technique coverage includes cleaning with detergents, buffers, chelators, enzymes, and other materials; disinfection using chemical, metal-based, ultraviolet, and related approaches; and sterilization through heat, ethylene oxide, radiation, and other validated technologies. EPA-classification analysis covers high-level, intermediate-level, and low-level disinfectants.
Regional coverage evaluates North America, Europe, Asia-Pacific, and the Middle East & Africa, with attention to healthcare infrastructure, infection-control standards, sterile-processing capacity, device utilization, automation, and supplier presence. Competitive coverage examines major manufacturers, specialist chemistry providers, sterilization companies, equipment developers, and instrument-care suppliers.
The study also evaluates market drivers, restraints, investment patterns, product innovation, regulatory influences, automation, sustainability, cleaning validation, digital traceability, endoscope reprocessing, outsourcing, and emerging sterile-processing models. It is designed to support manufacturers, healthcare providers, procurement teams, investors, distributors, and strategic planners assessing developments across the Medical Device Cleaning Market.
Medical Device Cleaning Market Report Scope & Segmentation
| Attributes | Details |
|---|---|
| Market Size (Current)Current market valuation | US$ 27.72 Billion in 2026 |
| Market Size (Forecast)Projected market valuation | US$ 65.91 Billion in 2035 |
| Growth RateCompound Annual Growth Rate | CAGR of 10.1% from 2026 to 2035 |
| Forecast PeriodAnalysis timeline | 2026 – 2035 |
| Base YearReference year for analysis | 2025 |
| Historical Data AvailablePast market data availability | Yes |
| Regional ScopeGeographical coverage | Global |
| Segments CoveredMarket segments analyzed | By Device
By Technique
By EPA Classification
|
Leading companies covered in this report
- STERIS plc (Ireland)
- Getinge AB (Sweden)
- Ecolab Inc. (U.S.)
- Advanced Sterilization Products (U.S.)
- Ruhof Corporation (U.S.)
- Metrex Research
- LLC (U.S.)
- Sklar Surgical Instruments (U.S.)
- Belimed AG (Switzerland)
- Steelco S.p.A. (Italy)
- Sterigenics U.S.
- and Oro Clean Chemie AG (Switzerland)
Frequently Asked Questions
Common questions about this report
The study period covers historical insights and forecast projections for the period 2026-2035.
The global Medical Device Cleaning Market market is expected to grow at a CAGR of 10.1% during the forecast period 2026-2035.
The report offers comprehensive market segmentation analysis across key categories and sub-segments relevant to the industry, along with regional and competitive insights.
The market is projected to reach 65.91 Billion by 2035.
STERIS plc (Ireland), Getinge AB (Sweden), Ecolab Inc. (U.S.), Advanced Sterilization Products (U.S.), Ruhof Corporation (U.S.), Metrex Research, LLC (U.S.), Sklar Surgical Instruments (U.S.), Belimed AG (Switzerland), Steelco S.p.A. (Italy), Sterigenics U.S., LLC (U.S.), and Oro Clean Chemie AG (Switzerland).
North America, Europe, and Asia Pacific are key regions covered in the report, including regional trends, market share, and growth opportunities.
Growing demand, technological advancements, changing consumer preferences, and increasing investments are some of the major factors supporting the growth of the Medical Device Cleaning Market market.
Yes, the report includes company profiling, competitive landscape analysis, strategic developments, mergers & acquisitions, product launches, and market positioning of leading industry participants.
The report is prepared using a combination of primary research, secondary research, expert interviews, industry databases, company annual reports, and proprietary market analysis models.
Yes, report customization options are available based on specific business objectives, geographic focus, competitive benchmarking requirements, and additional market segmentation needs.
Yes, the report is available in both PDF and Excel formats. The Excel file includes all market data tables, forecasts, and segment-wise data for easy analysis.
Yes, you can request a free sample report which includes an overview, table of contents, and sample data pages to help you evaluate the report before making a purchase decision.
About the Author
Market research expert with years of industry experience
Dipali Bhingare serves as the Market Research Director at Econ Market Research. With a focus on translating complex global economic shifts into actionable business intelligence, she oversees the strategic direction of comprehensive market studies. Her work empowers organizations to navigate volatile industries through data-driven forecasting and deep-dive competitive analysis.
